Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jun 20, 2017	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-17-208186.pdf 0001193125-17-208186.rtf 0001193125-17-208186.xls
Jun 20, 2017	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-17-208191.pdf 0001193125-17-208191.rtf 0001193125-17-208191.xls
Jun 14, 2019	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-19-173651.pdf 0001193125-19-173651.rtf 0001193125-19-173651.xls
Jun 14, 2019	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-19-173664.pdf 0001193125-19-173664.rtf 0001193125-19-173664.xls
Jun 12, 2020	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-20-167729.pdf 0001193125-20-167729.rtf 0001193125-20-167729.xls
Jul 21, 2020	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-20-196460.pdf 0001193125-20-196460.rtf
Jul 22, 2020	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-20-196929.pdf 0001193125-20-196929.rtf
Jun 11, 2021	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-21-188931.pdf 0001193125-21-188931.rtf 0001193125-21-188931.xls
Jul 14, 2021	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-21-215224.pdf 0001193125-21-215224.rtf
Jul 14, 2021	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-21-215351.pdf 0001193125-21-215351.rtf

Data provided by Kaleidoscope.